Pharmosa Biopharm (ROCO:6875) EV-to-Revenue : 26.24 (As of Jun. 06, 2024)

Pharmosa Biopharm EV-to-Revenue Chart

Pharmosa Biopharm Quarterly Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial									-	-	29.82	30.16	27.30

Competitive Comparison of Pharmosa Biopharm's EV-to-Revenue

For the Biotechnology subindustry, Pharmosa Biopharm's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmosa Biopharm's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmosa Biopharm's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Pharmosa Biopharm's EV-to-Revenue falls into.

Pharmosa Biopharm EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Pharmosa Biopharm's EV-to-Revenue for today is calculated as:

Pharmosa Biopharm's current Enterprise Value is NT$8,253.5 Mil.
Pharmosa Biopharm's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$314.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmosa Biopharm  (ROCO:6875) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Pharmosa Biopharm's PS Ratiofor today is calculated as:

Pharmosa Biopharm's share price for today is NT$73.70.
Pharmosa Biopharm's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$2.77.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmosa Biopharm EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Pharmosa Biopharm's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmosa Biopharm (ROCO:6875) Business Description